Skip to content

Randomized, double blinded placebo-controlled trial to determine the effect of Cinnamon extract on serum cholesterol levels in people with serum LDL level between 100 mg/dL – 190 mg/dL (100 mg/dL<LDL<190 mg/dL).

Randomized placebo-controlled trial to determine the effect of a standardized Cinnamon extract on serum cholesterol levels

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
SLCTR
Registry ID
SLCTR/2021/011
Enrollment
Unknown
Registered
2021-04-19
Start date
2021-04-19
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Serum LDL level between 100 mg/dL – 190 mg/dL (100 mg/dL<LDL<190 mg/dL)

Interventions

- The study will be a randomized, double-blinded, placebo-controlled clinical trial. It will be conducted at the Sri Jayewardenepura General Hospital, Sri Lanka for a period of 3 months, assessing the

Sponsors

SDS Spices (PVT) LTD
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: * Age between 18-70 years * Both male and female * LDL level; between 100 and 190 mg/dL (100 mg/dL < LDL < 190mg/dL)

Exclusion criteria

Exclusion criteria: • Participants with an allergy to cinnamon • Already on cinnamon or any other nutritional / herbal / ayurvedic supplements. • Lactation, pregnancy or unwillingness to use an effective form of birth control for women of childbearing years • Any form of malignancy at present or in the past • Blood dyscrasias • Estimated Glomerular Filtration Rate (eGFR) 300 mg/dL

Design outcomes

Primary

MeasureTime frame
Change in low density lipo-protein (LDL) levels from baseline to final follow-up at three months post randomization. [end of 3 months ]

Secondary

MeasureTime frame
Changes in other lipid profile parameters (HDL, total cholesterol and triglycerides) from baseline to end of study visit [At the end of 3 months from initiating the intervention] Changes in Fasting Blood Sugar (FBS) and HbA1c from baseline to end of study visit [At the end of 3 months from initiating the intervention] Changes in anthropometric parameters [Weight, waist circumference, hip circumference, and mid arm circumference] from baseline to end of study visit [ At each monthly follow up visit ] Change in systolic blood pressure and diastolic blood pressure from baseline to end of study visit. [ At each monthly follow up visit ] Potential effects of regular administration of C. zeylanicum extracts on liver and kidney function \ from baseline to end of study visit. Liver profile tests include Aspartate Aminotransferase (AST), Alanine Aminotransferase (ALT), Alkaline Phosphatase (AP). Renal profile tests include Serum creatinine, albumin creatinine ratio (ACR), Glomerular Filtration Rate (eGFR), electrolytes-Na, K, Cl [ At each monthly follow up visit ] Self-reported side effects in participants of the study from baseline to end of study visit. [At each monthly follow up visit]

Countries

Sri Lanka

Contacts

Public ContactDr Dimuthu Muthukuda

Consultant Endocrinologist

dimuthutm@yahoo.com

Outcome results

None listed

Source: SLCTR (via WHO ICTRP) · Data processed: Aug 9, 2026